MEDICLIN Aktiengesellschaft (MED.DE)
EUR 2.42
(0.0%)
EUR 2.42
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 70.03 Million EUR | -87.35% |
| 2022 | 553.42 Million EUR | 2.47% |
| 2021 | 540.1 Million EUR | -1.42% |
| 2020 | 547.89 Million EUR | 3.24% |
| 2019 | 530.67 Million EUR | 3.73% |
| 2018 | 511.57 Million EUR | 4.24% |
| 2017 | 490.75 Million EUR | 9.42% |
| 2016 | 448.51 Million EUR | 4.4% |
| 2015 | 429.6 Million EUR | 3.19% |
| 2014 | 416.31 Million EUR | 3.41% |
| 2013 | 402.59 Million EUR | 1.93% |
| 2012 | 394.99 Million EUR | 6.11% |
| 2011 | 372.26 Million EUR | 3.41% |
| 2010 | 359.96 Million EUR | 3.98% |
| 2009 | 346.19 Million EUR | 3.22% |
| 2008 | 335.4 Million EUR | 611.76% |
| 2007 | -65.53 Million EUR | -3.07% |
| 2006 | -63.58 Million EUR | -332.32% |
| 2005 | 27.37 Million EUR | 41.93% |
| 2004 | 19.28 Million EUR | -2.2% |
| 2003 | 19.71 Million EUR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 12.96 Million EUR | 1122.85% |
| 2024 Q1 | 11.78 Million EUR | 96.93% |
| 2023 Q4 | 5.98 Million EUR | -95.41% |
| 2023 Q2 | 141.05 Million EUR | -0.66% |
| 2023 Q3 | 130.38 Million EUR | -7.57% |
| 2023 Q1 | 141.99 Million EUR | 4.17% |
| 2023 FY | 70.03 Million EUR | -87.35% |
| 2022 Q3 | 133.66 Million EUR | -4.74% |
| 2022 FY | 553.42 Million EUR | 2.47% |
| 2022 Q1 | 143.11 Million EUR | 8.17% |
| 2022 Q4 | 136.31 Million EUR | 1.98% |
| 2022 Q2 | 140.32 Million EUR | -1.95% |
| 2021 Q1 | 139.73 Million EUR | 2.23% |
| 2021 Q2 | 137.99 Million EUR | -1.25% |
| 2021 Q3 | 130.05 Million EUR | -5.75% |
| 2021 Q4 | 132.31 Million EUR | 1.74% |
| 2021 FY | 540.1 Million EUR | -1.42% |
| 2020 Q4 | 136.69 Million EUR | 1.58% |
| 2020 FY | 547.89 Million EUR | 3.24% |
| 2020 Q3 | 134.56 Million EUR | 0.1% |
| 2020 Q2 | 134.43 Million EUR | -5.46% |
| 2020 Q1 | 142.19 Million EUR | 7.7% |
| 2019 Q2 | 132.64 Million EUR | -2.98% |
| 2019 Q4 | 132.03 Million EUR | 2.13% |
| 2019 FY | 530.67 Million EUR | 3.73% |
| 2019 Q1 | 136.72 Million EUR | 5.75% |
| 2019 Q3 | 129.27 Million EUR | -2.54% |
| 2018 Q4 | 129.29 Million EUR | 4.25% |
| 2018 FY | 511.57 Million EUR | 4.24% |
| 2018 Q1 | 128.98 Million EUR | -8.78% |
| 2018 Q2 | 129.01 Million EUR | 0.03% |
| 2018 Q3 | 124.02 Million EUR | -3.87% |
| 2017 Q4 | 141.4 Million EUR | 27.23% |
| 2017 Q3 | 111.14 Million EUR | -6.02% |
| 2017 Q2 | 118.26 Million EUR | -1.4% |
| 2017 Q1 | 119.94 Million EUR | 7.22% |
| 2017 FY | 490.75 Million EUR | 9.42% |
| 2016 Q1 | 113.76 Million EUR | 3.84% |
| 2016 Q2 | 112.72 Million EUR | -0.91% |
| 2016 Q3 | 110.15 Million EUR | -2.28% |
| 2016 Q4 | 111.87 Million EUR | 1.56% |
| 2016 FY | 448.51 Million EUR | 4.4% |
| 2015 Q4 | 109.55 Million EUR | 5.59% |
| 2015 FY | 429.6 Million EUR | 3.19% |
| 2015 Q3 | 103.75 Million EUR | -3.28% |
| 2015 Q2 | 107.27 Million EUR | -1.61% |
| 2015 Q1 | 109.02 Million EUR | 3.11% |
| 2014 Q2 | 103.95 Million EUR | -1.22% |
| 2014 Q1 | 105.24 Million EUR | 6.82% |
| 2014 Q4 | 105.73 Million EUR | 4.29% |
| 2014 Q3 | 101.38 Million EUR | -2.47% |
| 2014 FY | 416.31 Million EUR | 3.41% |
| 2013 Q2 | 102.43 Million EUR | 0.18% |
| 2013 Q4 | 98.52 Million EUR | -0.87% |
| 2013 FY | 402.59 Million EUR | 1.93% |
| 2013 Q1 | 102.25 Million EUR | 2.15% |
| 2013 Q3 | 99.39 Million EUR | -2.97% |
| 2012 Q2 | 98.78 Million EUR | -0.39% |
| 2012 Q3 | 96.92 Million EUR | -1.88% |
| 2012 Q4 | 100.1 Million EUR | 3.27% |
| 2012 FY | 394.99 Million EUR | 6.11% |
| 2012 Q1 | 99.17 Million EUR | 6.04% |
| 2011 Q2 | 186.9 Million EUR | 99.72% |
| 2011 Q4 | 93.52 Million EUR | 1.85% |
| 2011 Q1 | 93.58 Million EUR | 3.31% |
| 2011 FY | 372.26 Million EUR | 3.41% |
| 2011 Q3 | 91.82 Million EUR | -50.87% |
| 2010 Q4 | 90.58 Million EUR | 3.71% |
| 2010 Q3 | 87.34 Million EUR | -3.87% |
| 2010 Q2 | 90.86 Million EUR | -0.35% |
| 2010 Q1 | 91.18 Million EUR | 2.04% |
| 2010 FY | 359.96 Million EUR | 3.98% |
| 2009 Q4 | 89.36 Million EUR | 5.32% |
| 2009 FY | 346.19 Million EUR | 3.22% |
| 2009 Q1 | 85.74 Million EUR | 0.0% |
| 2009 Q3 | 84.84 Million EUR | -1.62% |
| 2009 Q2 | 86.24 Million EUR | 0.58% |
| 2008 FY | 335.4 Million EUR | 611.76% |
| 2007 FY | -65.53 Million EUR | -3.07% |
| 2006 FY | -63.58 Million EUR | -332.32% |
| 2005 FY | 27.37 Million EUR | 41.93% |
| 2004 FY | 19.28 Million EUR | -2.2% |
| 2003 FY | 19.71 Million EUR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 3.55 Billion EUR | 98.03% |
| Fresenius SE & Co. KGaA | 3.91 Billion EUR | 98.211% |
| LIMES Schlosskliniken AG | 11.2 Million EUR | -524.991% |
| M1 Kliniken AG | 16.77 Million EUR | -317.531% |
| Maternus-Kliniken Aktiengesellschaft | 17.48 Million EUR | -300.609% |
| RHÖN-KLINIKUM Aktiengesellschaft | 162.47 Million EUR | 56.895% |
| VITA 34 AG | 31.36 Million EUR | -123.296% |